Celsus Therapeutics Plc.
Celsus Therapeutics Plc. (CLTX) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 25 transactions totaling $856.7K, demonstrating a bullish sentiment with $856.7K in net insider flow. The most recent transaction on Jan 8, 2015 involved a transaction of 152,000 shares valued at $3.0K.
CLTX Insider Activity Summary
Who Is Buying CLTX Stock?
No significant insider buying has been recorded for CLTX in the recent period.
Who Is Selling CLTX Stock?
No significant insider selling has been recorded for CLTX in the recent period.
Is Celsus Therapeutics Plc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CLTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $856.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CLTX Frequently Asked Questions
Understanding CLTX Insider Activity
Insider trading at Celsus Therapeutics Plc. (CLTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CLTX stock, having executed 25 transactions in the past 90 days. The most active insider is Management, Llc Sabby (Executive), who has made 15 transactions totaling $666.0K.
Related Tools
Track Celsus Therapeutics Plc. Insider Activity
Get notified when executives and directors at CLTX file new Form 4 transactions